Flagellin or lipopolysaccharide treatment modified macrophag populations after colorectal radiation of rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 346, Issue 1, 2013, Pages 75-85

  Lacavé Lapalun, Jean Victor ^a   Benderitter, Marc ^a   Linard, Christine ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD163 ANTIGEN; CHEMOKINE; CYCLINE; FLAGELLIN; INTERLEUKIN 10; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; COLORECTAL DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPT CELL; EPITHELIUM CELL; MACROPHAGE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RAT; TISSUE INJURY; TISSUE REPAIR;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLAGELLIN; INTESTINAL MUCOSA; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MOLECULAR TARGETED THERAPY; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RECTUM; REGENERATION; SPECIFIC PATHOGEN-FREE ORGANISMS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5;

EID: 84879294248     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.204040     Document Type: Article

References (36)

1. Abderrahmani R, François A, Buard V., Tarlet G, Blirando K, Hneino M., Vaurijoux A, Benderitter M, Sabourin J.C., and Milliat F (2012) PAI-1-dependent endothelial cell death determines severity of radiation-induced intestinal injury. PLoS ONE 7: e35740.
2. Alderson MR, McGowan P, Baldridge J.R., and Probst P (2006) TLR4 agonists as immunomodulatory agents. J Endotoxin Res 12:313-319.
3. Biswas SK and Lopez-Collazo E (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30:475-487.
4. Brown BN, Valentin JE, Stewart-Akers AM, McCabe G.P., and Badylak SF (2009) Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30:1482-1491.
5. Burdelya LG, Krivokrysenko VI, Tallant T.C., Strom E., Gleiberman AS, Gupta D, Kurnasov OV, Fort F.L., Osterman AL, and Didonato JA, et al (2008) An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320:226-230.
6. Daley JM, Brancato SK, Thomay A.A., Reichner JS, and Albina JE (2010) The phenotype of murine wound macrophages. J Leukoc Biol 87:59-67.
7. De Jaeger K., Seppenwoolde Y, Kampinga H.H., Boersma LJ, Belderbos JS, and Lebesque JV (2004) Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58:1378-1387.
8. Frolova L, Drastich P, Rossmann P., Klimesova K, and Tlaskalova-Hogenova H (2008) Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem 56: 267-274.
9. Gewirtz AT (2003) Intestinal epithelial toll-like receptors: to protect. And serve? Curr Pharm Des 9:1-5.
10. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
11. Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer N.V., West ML, Jenq RR, Holland AM, and Kappel LW, et al (2012) Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37:339-350.
12. Ivashkiv LB (2011) Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 41:2477-2481.
13. Jenkins SJ, Ruckerl D, Cook P.C., Jones LH, Finkelman FD, van Rooijen N, MacDonald AS, and Allen JE (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332:1284-1288.
14. Jones RM, Sloane VM, Wu H, Luo L., Kumar A, Kumar MV, Gewirtz A.T., and Neish AS (2011) Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity. Gut 60:648-657.
15. Kinnebrew MA, Buffie CG, Diehl G.E., Zenewicz LA, Leiner I, Hohl TM, Flavell R.A., Littman DR, and Pamer EG (2012) Interleukin 23 production by intestinal CD103 (1)CD11b(1) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36:276-287.
16. Lang R, Patel D, Morris J.J., Rutschman RL, and Murray PJ (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169:2253-2263.
17. Linard C, Billiard F, and Benderitter M (2012) Intestinal irradiation and fibrosis in a Th1-deficient environment. Int J Radiat Oncol Biol Phys 84:266-273.
18. Mantovani A, Sica A, and Locati M (2005) Macrophage polarization comes of age. Immunity 23:344-346.
19. Menzies FM, Henriquez FL, Alexander J, and Roberts CW (2010) Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation. Clin Exp Immunol 160: 369-379.
20. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73: 209-212.
21. Murray PJ and Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723-737.
22. Nomura Y, Takeuchi M, Yoshida S., Sugita Y, Niino D, Kimura Y., Shimizu K, Aoki R, Suefuji N., and Hirose S, et al (2009) Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis. Pathol Int 59:631-635.
23. O'Brien PC (2001) Radiation injury of the rectum. Radiother Oncol 60:1-14.
24. Park-Min K.H., Antoniv TT, and Ivashkiv LB (2005) Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology 210:77-86.
25. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson M.S., El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray P.J., and Wynn TA (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5:e1000371.
26. Pollard JW (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9:259-270.
27. Rastogi S, Boylan M, Wright E.G., and Coates PJ (2013) Interactions of apoptotic cells with macrophages in radiation-induced bystander signaling. Radiat Res 179: 135-145.
28. Riehl T, Cohn S, Tessner T., Schloemann S, and Stenson WF (2000) Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 118:1106-1116.
29. Riehl TE, Newberry RD, Lorenz R.G., and Stenson WF (2004) TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. Am J Physiol Gastrointest Liver Physiol 286:G166-G173.
30. Skwarchuk MW and Travis EL (1998) Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains. Int J Radiat Oncol Biol Phys 42: 169-178.
31. Stout RD, Jiang C, Matta B., Tietzel I, Watkins SK, and Suttles J (2005) Macrophages sequentially change their functional phenotype in response to changes in micro-environmental influences. J Immunol 175:342-349.
32. Sun EW and Shi YF (2001) Apoptosis: the quiet death silences the immune system. Pharmacol Ther 92:135-145.
33. Vijay-Kumar M., Aitken JD, Sanders C.J., Frias A., Sloane VM, Xu J, Neish AS, Rojas M, and Gewirtz AT (2008) Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol 180:8280-8285.
34. Vijay-Kumar M and Gewirtz AT (2009) Flagellin: key target of mucosal innate immunity. Mucosal Immunol 2:197-205.
35. Wu WK, Llewellyn OP, Bates D.O., Nicholson LB, and Dick AD (2010) IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology 215:796-803.
36. Zhang H, Han G, Liu H., Chen J, Ji X, Zhou F., Zhou Y, and Xie C (2011) The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice. J Radiat Res (Tokyo) 52:717-726.